CHPA Kava Voluntary Warning Advises Against Driving
This article was originally published in The Tan Sheet
Executive Summary
The Consumer Healthcare Products Association has adopted a voluntary program for member companies producing kava kava supplements to include a label warning about the botanical's ability to induce drowsiness.
You may also be interested in...
Aristolochic Acids Kidney AEs Subject Of Pending FDA Import Alert
Herbal products containing aristolochic acids have been linked to reports of kidney failure and will be the subject of an import alert in the near future, FDA says in a May 16 letter to industry.
St. John's Wort, Rx Drug Use Warning Adopted By CHPA
Consumer Healthcare Products Association member companies soon will be incorporating a prescription drug use warning on their St. John's wort supplements.
Supplements Pregnancy Warning Statement Petition Pending From CHPA
The inclusion of a pregnancy/nursing warning on dietary supplement labeling is encouraged by the Consumer Healthcare Products Association in a new voluntary labeling program for its members.